Archives

Smaller portions, more protein: How GLP-1s are quietly changing chain restaurant menus – NBC News

Smaller portions, more protein: How GLP-1s are quietly changing chain restaurant menus  NBC News ‘Bar Rescue’ host Jon Taffer on new restaurant reality: Smaller portions, lighter appetites and higher costs  Fox Business How GLP-1 weight-loss drugs are changing Connecticut’s food scene  CT Insider Smaller portions, fewer second drinks: How restaurateurs are adapting to changing consumer trends  Inquirer.com Celebrity chef […]

Is Novo Nordisk’s Oral Wegovy Driving Strong Early US Demand Already?

Shares of Novo Nordisk NVO rose 9.1% on Friday after the company reportedly recorded strong early prescription trends just one week following the early-January U.S. launch of the oral version of its blockbuster GLP-1 therapy, Wegovy (semaglutide). The pill, approved in late December for obesity and cardiovascular risk reduction, is reportedly seeing robust initial demand, […]

Ozempic no replacement for willpower when it comes to weight loss

A new meta-study — a study of studies — reveals an inconvenient truth about weight loss itself: Willpower still matters. Manufacturers of GLP-1 injectables like Wegovy and Ozempic would prefer we forget that, since forgetting it is profitable. The counter-claim — that diets and exercise are no match for our genes and environment — is […]

The ‘biohacking’ trend that has tech workers experimenting on themselves

In an industry known for pushing the bounds of human innovation, tech elites are now trying to push the bounds of their own bodies. The hot new biohacking trend is injectable peptides — similar to the ones found in GLP-1 medications like Ozempic. But these are not approved by the Food and Drug Administration. These […]

What is “triple strength” Wegovy, and why has the MHRA approved it?

GLP-1 agonist injections, although originally developed to treat type 2 diabetes, have changed how we approach obesity.1 The two main types now in use—semaglutide (Wegovy), produced by Novo Nordisk, and tirzepatide (Mounjaro), produced by Eli Lilly—have been shown in clinical trials to produce substantial weight loss of 15-20% depending on dose, duration, and adherence.On 6 […]

I’m a gastroenterologist. Here are some surprising GLP-1 gut benefits

Trisha Parsicha in The Washington Post: In the original clinical trials of GLP-1 medications for weight loss, the most common side effects were gastrointestinal, including nausea, vomiting and constipation. Ask almost anyone who’s been on one, and they’ll probably tell you that they’ve had some GI issues — even if very mild. So you might be surprised that […]